Bioabsorbable Evolution
Advancements in PLGA formulations ensure controlled degradation rates that align perfectly with the bone healing process, eliminating secondary removal operations.
Bonevia
Bonevia
Pioneering clinical excellence with surgical-grade reconstruction implants and instruments engineered for optimal patient outcomes.
Bridging engineering brilliance and clinical precision to satisfy global market demands.
The global sports medicine and orthopedic implants market is undergoing a seismic shift. Rapid technological innovations, combined with aging populations striving to maintain active lifestyles and an increase in sports-related injuries, have placed unprecedented demands on manufacturers and exporters. Clinical professionals are shifting away from invasive surgical reconstructions toward minimally invasive arthroscopic surgery, which accelerates recovery times, minimizes postoperative complications, and decreases overall healthcare expenditures.
This tectonic industry transition relies on the structural integrity, biomechanical compatibility, and long-term reliability of implantable devices such as suture anchors, interference screws, and cortical fixation buttons. High-performance bioabsorbable polymers, including Poly(L-lactide-co-glycolide) (PLGA) and Polyetheretherketone (PEEK), are rapidly replacing standard titanium alloys in specific indications due to their modulus of elasticity matching natural human bone structure, reducing stress-shielding effects.
Establishing new standards of manufacturing efficiency and technical reliability in orthopedic implants since 2015.
Bonevia Orthopedic Technology Co., Ltd. is a leading professional manufacturer specializing in orthopedic implants and surgical solutions, dedicated to advancing innovation in trauma, spine, and joint reconstruction products. Since our establishment in 2015, we have grown steadily into a trusted partner in the global orthopedic industry. Our facility operates with extreme precision, leveraging a modern production facility covering approximately 320㎡ which houses advanced cleanrooms and micro-machining centers.
Supported by 6 years of export experience and over 10 years of overall industry experience, we maintain an annual export revenue of around USD 8–15 million. Quality assurance is our core focus: we implement multiple inspection methods including incoming material inspection, in-process quality control, and final product testing, supported by a dedicated quality team of 35 professionals.
How Bonevia achieves unrivaled quality control and rapid prototyping capabilities.
In the high-stakes sector of orthopedic surgery, component traceablity and material purity are paramount. Bonevia utilizes an integrated Factory 4.0 model, embedding full digital monitoring into every stage of the manufacturing cycle. From raw material sourcing through our 850+ partner ecosystem to the final micro-polishing of surgical instruments, every step is registered in our manufacturing execution system (MES).
This localized cluster allows Bonevia to maintain unparalleled supply chain resilience. Even during periods of global logistics volatility, our access to raw medical-grade titanium and high-purity polymers remains uninterrupted. Furthermore, our R&D engineering hub, comprising 85 experienced engineers, released 120 new product designs last year alone, offering customized OEM/ODM services to match evolving surgical techniques.
Engineered options built to satisfy strict European, American, and global medical regulations.
Selecting the optimal implant configuration based on localized joint kinematics and biological conditions.
Orthopedic sports medicine involves treating highly stressed anatomical zones, specifically the knee (ACL/PCL, meniscus) and the shoulder (rotator cuff, labral complex, glenohumeral instability). Selecting the appropriate implant material is critical:
Essential technical insights and regulatory details for global procurement directors.
High-durability arthroscopic instruments and consumables manufactured to clinical standards.
